期刊文献+

子痫前期患者可溶性血管内皮生长因子及其受体与子宫胎盘床螺旋动脉变化及意义 被引量:2

Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 and the alteration of the placental bed spiral arteries in preeclampsia
下载PDF
导出
摘要 目的研究可溶性血管内皮生长因子受体1(sFlt-1)和血管内皮生长因子(VEGF)在子痫前期患者血清中的浓度变化,以及子宫胎盘床螺旋动脉的相应变化,探讨sFlt-1和VEGF在子痫前期中的作用。方法采用酶联免疫吸附试验(ELISA)分别测定轻度子痫前期、重度子痫前期患者及正常妊娠妇女外周血清中sFlt-1和VEGF的浓度。同时按照Robertson方法,获取胎盘床活检标本,在光学显微镜下观察子痫前期组与对照组胎盘床螺旋动脉的生理性变化。结果(1)子痫前期组各组外周血清中sFlt-1水平明显高于对照组(P<0.01),子痫前期重度组高于子痫前期轻度组(P<0.05);(2)子痫前期组各组外周血血清中VEGF水平明显低于对照组(P<0.05),子痫前期重度组低于子痫前期轻度组(P<0.05)。正常妊娠组与子痫前期组胎盘床蜕膜螺旋动脉的生理性改变差异无统计学意义(P>0.05)。子痫前期组肌层螺旋动脉的生理性改变明显少于正常妊娠组,2组差别有统计学意义(P<0.05)。结论外周血中升高的sFlt-1和降低的VEGF以及相应的肌层螺旋动脉生理性改变可能与妊娠期高血压的发病有关,并参与了子痫前期病理生理过程。 Objective To investigate the alteration of serum vascular endothelial growth factor and soluble fins-like tyrosine kinase receptor 1(sFlt-1) in patients with preeclampsia. And the correlation of the placental bed spiral arteries and the role role of sFlt-1 and VEGF preeclampisa pathophysiology. Methods Serum vascular endothelial growth factor and soluble fms - like t^sine kinase receptor 1 in peripheral venous blood were determined by ELISA in patients with preeclampsia, severe preeclampsia and healthy controls. Accosting to the Robertson' s methods, the placental bed was obtained by biopsies. The physiological changes of spiral arteries were comparatively studied with light microscope. Results Patients with preeclampsia had higher level of serum sFlt-1 and lower serum level of VEGF than that in control group( P 〈 0.01 ) . There were no significant differences between normal pregnanceis and preeclampsia patients in physiological changes of deciduas segments of spiral arteries ( P 〉 0.05). The physiological changes of myometrium spiral arteries in preeclampsia were markedly less than that in normal pregnanoy ( P 〈 0.05). Conclusion The happening of preeclampsia was related closely to the decrease of physiological changes in myometrium spiral arteries of placental bed. Elevated of serum sFlt-1 and decreased VEGF as well as the alteration of the placental bed spiral arteries may be contributed to the pathogenesis of preeclampsia.
出处 《河北医药》 CAS 2008年第5期586-587,共2页 Hebei Medical Journal
关键词 子痫前期 可溶性血管内皮生长因子受体-1 血管内皮生长因子 胎盘床螺旋动脉 precclampsia sFlt-1 VEGF the placental bed spiral arteries
  • 相关文献

参考文献8

  • 1林其德.妊娠高血压综合征病因学研究进展与展望[J].中华妇产科杂志,2003,38(8):471-473. 被引量:138
  • 2Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of thesoluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. The J of Clin Endo & Meta, 2003,88: 5555-5563.
  • 3Dixon HG, Robertson WB. A study of the vessels of the placental bed in normo tensive and hypertensive woman.J Obstet Gynaeco IB r Emp, 1958,65:803.
  • 4Roberts JM, Cooper DW. pathogenesis and genetics of Preeclampsia. Lancet, 2001,357 : 53-56.
  • 5Richard L, Kendall M, Kenneth A, et al. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA, 1993,90:10705-10709.
  • 6Barleon B, Reusch P, Totzke F, et al. Soluble VEGFR-1 secreted by endothelial cell and monocytes is present in human serum plasma form healthy donors. Angiogenesis, 2001,4 : 143 - 154.
  • 7David L. Placental protein may have arole in pre-eclampsia. Lancet, 2003, 361:940-941.
  • 8Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase I (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest, 2003,649-658.

二级参考文献1

共引文献137

同被引文献21

  • 1袁祎,徐巧霖,李丽洁,周锦红.妊娠晚期血管内皮生长因子、同型半胱氨酸、血清白蛋白、血尿酸与子痫前期的相关性分析[J].心脑血管病防治,2020(3):310-312. 被引量:6
  • 2Nylen KJ,O'Hara MW,Engeldinger J. Perceived social support interacts with prenatal depression to predict birth outcomes[J].{H}Journal of Behavioral Medicine,2012.1-14.
  • 3Smith GC,Shah I,Crossley JA. Pregnancy-associated plasma protein A and alpha fetoprotein and prediction of adverse perinatal outcome[J].{H}OBSTETRICS AND GYNECOLOGY,2006,(1):161-166.
  • 4Kusanovic J P,Romero R,Chaiworapongsa T. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia[J].{H}JOURNAL OF MATERNAL-FETAL AND NEONATAL MEDICINE,2009,(11):1021-1038.
  • 5Schroeder BM. Practice Guidelines ACOG Practice Bulletin on Diagnosing and Managing Preeclampsia and Eclampsia[J].{H}AMERICAN FAMILY PHYSICIAN,2002,(2):330-331.
  • 6Chaiworapongsa T,Romero R,Tarca A L. A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia[J].{H}American Journal of Obstetrics and Gynecology,2010,(6):550.e1-550.e10.
  • 7Benton SJ,Hu Y,Xie F. Angiogenic factors as diagnostic tests for preeclampsia:a performance comparison between two commercial immunoassays[J].A merican Journal of Obstetrics and Gynecology,2011,(5):469.e1-469.e8.
  • 8Maynard SE,Min JY,Merchan J. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction,hypertension,and proteinuria in preeclampsia[J].{H}Journal of Clinical Investigation,2003,(5):649-658.
  • 9Ahmed A. New insights into the etiology of preeclampsia:identification of key elusive factors for the vascular complications[J].{H}Thrombosis research,2011.S72-S75.
  • 10Crispi F,Domínguez C,Llurba E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction[J].{H}American Journal of Obstetrics and Gynecology,2006,(1):201-207.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部